Please assess the completion status of the following clinical trial:

Trial Title: The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* diagnosis of idiopathic Restless Legs Syndrome, confirmed by a score of at least 11 on the RLS Diagnostic Index~* certain severity of symptoms (at least score of 15 on the International Restless Legs Score (IRLS)~* Have had RLS symptoms for at least 15 nights in the last four weeks.~* \< 6 hours of sleep in nights with RLS symptoms~* MADRS (depression rating scale) score of at least 12 (= borderline to depression) at baseline~Exclusion criteria:~* any other sleep disorder that might interfere with the RLS symptoms or sleep (e.g. sleep apnea disorder, narcolepsy)~* Secondary RLS due to diagnosis of renal insufficiency, polyneuropathy, pregnancy (see below), iron deficiency anemia~* Any significant psychiatric disorders (e.g. schizophrenia, bipolar disorder); depression which by judgement of the investigator is caused by RLS, is not an exclusion criterion.~* Current or past suicidality~* medication known to trigger/aggravate/ cause or interfere with RLS symptoms (e.g. most antidepressants, lithium, neuroleptics, opioids, carbidopa, clonidine, antihistamines, anticonvulsants etc.).~* daytime RLS symptoms which require treatment (daytime: 10 a.m. until 6 p.m.).~* concomitant movement disorders (e.g. Parkinson's Disease, dyskinesia, dystonia).~* medical conditions with symptoms which could affect assessments of efficacy (e.g. diabetes, rheumatoid arthritis, fibromyalgia syndrome, cancer etc.).~* Subjects taking any medication known to induce drowsiness or to affect sleep.~* Subjects who are pregnant, lactating or of childbearing potential. Women of childbearing potential must use adequate contraception~* clinically significant or unstable medical conditions (e.g. severe heart disease, severe liver or kidney disease etc.).~* pain syndromes, caused by other disorders than RLS~* excessive caffeine intake~* diastolic blood pressure \>110mmHg or \<50mmHg or systolic blood pressure \>180mmHg or \<90mmHg at baseline.~* Withdrawal, introduction, or change in dose of hormone replacement therapy (HRT) or the oral contraceptive pill (OCP) and/or certain drugs which are known to interact with ropinirole (e.g. ciprofloxacin, cimetidine, tobacco, omeprazole).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).